Evidence check: WeightLoss | SLIM DNA-Test in the context of Schlaf

The SLIM DNA-Test (or similar weight-loss genetic tests) often claims personalized recommendations based on variants like FTO, MC4R, or VDR. However, the scientific evidence is limited: FTO rs9939609 (A allele) is associated with higher BMI (GWAS p=4e-51), but the effect per allele is only ~0.3 BMI units. A direct impact on sleep quality or chronotype is not established – only an indirect link via sleep apnea in severe obesity. VDR variants affect vitamin D metabolism, and low vitamin D is linked to poorer sleep, but a causal effect on circadian rhythm is lacking. The Mediterranean-fiber diet, in contrast, shows robust human evidence for weight loss, reduced inflammation, and improved microbiome diversity – independent of genotype. Bottom line: A DNA test alone is insufficiently validated for weight loss and sleep. More actionable are biomarkers like HbA1c, hs-CRP, or blood vitamin D levels. Evidence is mixed: mechanistic and observational, but not strong enough for clinical recommendations.